These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20392316)

  • 1. Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis.
    Eddama O; Petrou S; Regier D; Norrie J; MacLennan G; Mackenzie F; Norman JE
    Int J Technol Assess Health Care; 2010 Apr; 26(2):141-8. PubMed ID: 20392316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and cost effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial.
    Pizzi LT; Seligman NS; Baxter JK; Jutkowitz E; Berghella V
    Pharmacoeconomics; 2014 May; 32(5):467-78. PubMed ID: 24715602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis.
    Norman JE; Mackenzie F; Owen P; Mactier H; Hanretty K; Cooper S; Calder A; Mires G; Danielian P; Sturgiss S; MacLennan G; Tydeman G; Thornton S; Martin B; Thornton JG; Neilson JP; Norrie J
    Lancet; 2009 Jun; 373(9680):2034-40. PubMed ID: 19523680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ; Nguyen LK; Pham TD; He YTN; Vu KN; Phan MTN; Le TQ; Le CH; Vuong LN; Mol BW
    Obstet Gynecol; 2019 Mar; 133(3):459-467. PubMed ID: 30741812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour.
    Eddama O; Petrou S; Schroeder L; Bollapragada SS; Mackenzie F; Norrie J; Reid M; Norman JE
    BJOG; 2009 Aug; 116(9):1196-203. PubMed ID: 19485990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of early administration of rectal progesterone in IVF/ICSI twin pregnancies on the preterm birth rate: a randomized trial.
    Aboulghar MM; El-Faissal Y; Kamel A; Mansour R; Serour G; Aboulghar M; Islam Y
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):351. PubMed ID: 32517660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last.
    Romero R
    Womens Health (Lond); 2011 Sep; 7(5):501-4. PubMed ID: 21879816
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial.
    Petrou S; Bischof M; Bennett C; Elbourne D; Field D; McNally H
    Pediatrics; 2006 May; 117(5):1640-9. PubMed ID: 16651318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012024. PubMed ID: 29086920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study.
    Brizot ML; Hernandez W; Liao AW; Bittar RE; Francisco RPV; Krebs VLJ; Zugaib M
    Am J Obstet Gynecol; 2015 Jul; 213(1):82.e1-82.e9. PubMed ID: 25731690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
    Serra V; Perales A; Meseguer J; Parrilla JJ; Lara C; Bellver J; Grifol R; Alcover I; Sala M; Martínez-Escoriza JC; Pellicer A
    BJOG; 2013 Jan; 120(1):50-7. PubMed ID: 22882759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a preventive counseling and support package for postnatal depression.
    Petrou S; Cooper P; Murray L; Davidson LL
    Int J Technol Assess Health Care; 2006; 22(4):443-53. PubMed ID: 16984677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.
    Klein K; Rode L; Nicolaides KH; Krampl-Bettelheim E; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):281-7. PubMed ID: 21739499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J;
    Lancet; 2016 May; 387(10033):2106-2116. PubMed ID: 26921136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.